Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Smart Eye in connection with a directed issue of new shares
Mandate

Vinge advises Smart Eye in connection with a directed issue of new shares

September 19, 2018 Capital Markets and Public M&A

Vinge has advised Smart Eye AB (publ) in connection with a directed issue of new shares to institutional investors as a result of which Swedbank Robur Ny Teknik will become a significant owner with 7.6% of the votes and capital.

The subscription price, i.e. SEK 52 per share, has been determined through a so called accelerated book building process. As a result of new share issue, Smart Eye has acquired approximately MSEK 114. Carnegie Investment Bank acted as financial adviser and sole book runner.

Vinge’s team primarily consisted of Anders Strid, Wibeke Sorling and company registration assistant Camilla Andersson.
 

Related

Vinge advises Consolid Equity in connection with the establishment of Petra Group

 Vinge has advised Consolid Equity Investment AB ("Consolid Equity") on the acquisition of Ström & Gulliksson, one of the leading patent agencies in the Nordics. The acquisition forms part of the establishment of Petra Group, a European platform aimed at consolidating patent agencies across Europe to combine expertise and resources primarily within patents and trademarks. Consolid acts as a strategic partner in the new group.
July 08, 2026

Vinge has advised Scandic on new credit facilities with SEK 7.5 billion credit facilities

 Vinge has represented Scandic Hotels Group AB (publ) in connection with a facilities agreement for SEK 7,500,000,000 with a syndicate of banks, arranged by DNB Carnegie Investment Bank AB and Nordea Bank Abp, filial i Sverige.
July 08, 2026

Vinge has advised Vitamin Well and its majority shareholders Cinven, Bridgepoint and the founders on Vitamin Well's combination with EMPWR

 Vinge has advised Vitamin Well and its majority shareholders Cinven, the founders of Vitamin Well and Bridgepoint on Vitamin Well's acquisition of EMPWR Nutrition Group from majority seller Waterland Private Equity Investments.
July 03, 2026